Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term antitumor agents. Found 3 abstracts

Malyuchenko NV, Kotova EY, Kulaeva OI, Kirpichnikov MP, Studitskiy VM. PARP1 Inhibitors: antitumor drug design. Acta Naturae. 2015 Jul;7(3):27-37.   PMCID: PMC4610162
Giantonio BJ, Alpaugh RK, Schultz J, McAleer C, Newton DW, Shannon B, Guedez Y, Kotb M, Vitek L, Persson R, Gunnarsson PO, Kalland T, Dohlsten M, Persson B, Weiner LM. Superantigen-based immunotherapy: A phase I trial of PNU- 214565, a monoclonal antibody staphylococcal enterotoxin a recombinant fusion protein, in advanced pancreatic and colorectal cancer. Journal of Clinical Oncology. 1997 May;15(5):1994-2007.
Lambert B, Jestin JL, Brehin P, Oleykowski C, Yeung AT, Mailliet P, Pretot C, Lepecq JB, Jacqueminsablon A, Chottard JC. Binding of the Escherichia-Coli Uvrab Proteins to the DNA Monoadducts and Diadducts of Cis- N-2-Amino-N-2-Methylamino- 2,2,1-Bicycloheptane Dichloroplatinum(Ii) and Cisplatin - Analysis of the Factors Controlling Recognition and Proof of Monoadduct-Mediated Uvrb-DNA Cross-Linking. Journal of Biological Chemistry. 1995 Sep 08;270(36):21251-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term antitumor agents

Last updated on Friday, June 05, 2020